Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Partial Seizure”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Enrolling By InvitationNCT05718817
What this trial is testing

An Open-label Study of XEN1101 in Epilepsy

Who this might be right for
Focal EpilepsyTonic-Clonic Seizures
Xenon Pharmaceuticals Inc. 880
Not applicableStudy completedNCT01457989
What this trial is testing

Meta-Analysis Plan for Pooled Data for Studies VRX-RET-E22-303 and VRX-RET-E22-304

Who this might be right for
Epilepsy, Partial
GlaxoSmithKline 1
Testing effectiveness (Phase 2)Study completedNCT01527513
What this trial is testing

Effects of Eslicarbazepine Acetate (Esl, Bia 2-093) on Cognitive Function in Children With Partial Onset Seizures

Who this might be right for
Partial Epilepsy
Bial - Portela C S.A. 123
Not applicableUnknownNCT05635396
What this trial is testing

Seizures Detection in Real Life Setting

Who this might be right for
Epilepsy; SeizureFocal Epilepsy
Reliev Technologies 12
Large-scale testing (Phase 3)Study completedNCT00310375
What this trial is testing

Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial

Who this might be right for
Epilepsy
GlaxoSmithKline 181
Not applicableStudy completedNCT01178437
What this trial is testing

Transcutaneous Non-invasive Stimulation of the Vagus Nerve for the Treatment of Difficult-to-treat Epilepsy

Who this might be right for
Epilepsy
cerbomed GmbH 7
Not applicableStudy completedNCT01098162
What this trial is testing

Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic Drug

Who this might be right for
Epilepsies, Partial
UCB Pharma GmbH 576
Testing effectiveness (Phase 2)Ended earlyNCT04686786
What this trial is testing

An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Who this might be right for
Seizures
AbbVie 105
Large-scale testing (Phase 3)Study completedNCT00490035
What this trial is testing

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma SA 399
Large-scale testing (Phase 3)Ended earlyNCT00067431
What this trial is testing

The Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children

Who this might be right for
Partial Seizure Disorder
Abbott 300
Not applicableStudy completedNCT00001666
What this trial is testing

Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial Epilepsy

Who this might be right for
Partial EpilepsySeizures
National Institute of Neurological Disorders and Stroke (NINDS) 32
Large-scale testing (Phase 3)Study completedNCT00520741
What this trial is testing

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Who this might be right for
Epilepsy
UCB BIOSCIENCES, Inc. 426
Post-approval studies (Phase 4)Active Not RecruitingNCT06453213
What this trial is testing

Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy

Who this might be right for
Focal Onset Seizure
SK Life Science, Inc. 49
Large-scale testing (Phase 3)Study completedNCT00143130
What this trial is testing

Pregabalin In Partial Seizures Extension Study

Who this might be right for
Seizures
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 227
Not applicableLooking for participantsNCT03478852
What this trial is testing

Investigating Epilepsy: Screening and Evaluation

Who this might be right for
SeizuresEpilepsyEpilepsy, Temporal Lobe+1 more
National Institute of Neurological Disorders and Stroke (NINDS) 1,000
Testing effectiveness (Phase 2)Study completedNCT01866111
What this trial is testing

A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures

Who this might be right for
Partial Epilepsy
SK Life Science, Inc. 437
Large-scale testing (Phase 3)Study completedNCT01142193
What this trial is testing

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Who this might be right for
Epilepsy
Upsher-Smith Laboratories 249
Testing effectiveness (Phase 2)WithdrawnNCT00982787
What this trial is testing

Safety and Anticonvulsant Efficacy of Passiflora Incarnata Extract in Patients With Partial Epilepsy

Who this might be right for
Partial Epilepsy
Oregon Health and Science University
Large-scale testing (Phase 3)Study completedNCT00280696
What this trial is testing

Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures

Who this might be right for
Epilepsies, Partial
UCB Japan Co. Ltd. 352
Large-scale testing (Phase 3)WithdrawnNCT03108729
What this trial is testing

A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug

Who this might be right for
Epilepsy
Sumitomo Pharma America, Inc.
Next Page